» Articles » PMID: 7585257

Identification of HnRNP P2 As TLS/FUS Using Electrospray Mass Spectrometry

Overview
Journal RNA
Specialty Molecular Biology
Date 1995 Sep 1
PMID 7585257
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Protein complexes assembled on mRNA precursors can be separated by gel filtration chromatography to yield spliceosomal and H complex fractions (Reed R, Griffith J, Maniatis T, 1988, Cell 53:949-961; Reed R, 1990, Proc Natl Acad Sci USA 87:8031-8035.). Here we use Nano electrospray mass spectrometry (Wilm M, Mann M, 1994, Int J Mass Spectrometry Ion Processes 136:167-180) to identify proteins complexed with Adeno-pre-mRNA in the H complex peak. Four of the major hnRNP proteins, A1, B1, C1, and G, were identified by database analysis based on peptide mass and sequence information. A fifth protein in the H complex peak, corresponding to hnRNP P2, is shown to be the product of the TLS/FUS gene. This was originally identified as a chimeric oncogene formed by the chromosome translocation t(12;16) that is responsible for myxoid liposarcoma. The involvement of hnRNP P2 in oncogenesis provides a clear example of the importance of hnRNP proteins in molecular disease.

Citing Articles

Amyotrophic Lateral Sclerosis Genes in .

Layalle S, They L, Ourghani S, Raoul C, Soustelle L Int J Mol Sci. 2021; 22(2).

PMID: 33477509 PMC: 7831090. DOI: 10.3390/ijms22020904.


Trends in Understanding the Pathological Roles of TDP-43 and FUS Proteins.

Buratti E Adv Exp Med Biol. 2021; 1281:243-267.

PMID: 33433879 DOI: 10.1007/978-3-030-51140-1_15.


The role of hnRNPs in frontotemporal dementia and amyotrophic lateral sclerosis.

Bampton A, Gittings L, Fratta P, Lashley T, Gatt A Acta Neuropathol. 2020; 140(5):599-623.

PMID: 32748079 PMC: 7547044. DOI: 10.1007/s00401-020-02203-0.


FUS Recognizes G Quadruplex Structures Within Neuronal mRNAs.

Imperatore J, McAninch D, Valdez-Sinon A, Bassell G, Mihailescu M Front Mol Biosci. 2020; 7:6.

PMID: 32118033 PMC: 7018707. DOI: 10.3389/fmolb.2020.00006.


Nuclear-cytoplasmic Shuttling in Chronic Myeloid Leukemia: Implications in Leukemia Maintenance and Therapy.

Carra G, Russo I, Guerrasio A, Morotti A Cells. 2019; 8(10).

PMID: 31614958 PMC: 6830087. DOI: 10.3390/cells8101248.